Literature DB >> 20231114

Myotonic dystrophy type 1 and PGD: ovarian stimulation response and correlation analysis between ovarian reserve and genotype.

C Dechanet1, C Castelli, L Reyftmann, C Coubes, S Hamamah, B Hedon, H Dechaud, T Anahory.   

Abstract

This study aimed at evaluating parameters and results of ovarian stimulation for myotonic dystrophy type 1 (DM1) female patients undergoing preimplantation genetic diagnosis (PGD) and to assess an eventual association between genotype and ovarian reserve. A retrospective study involved all 17 DM1 patients treated in the study centre's PGD programme. The control group consisted of 22 patients treated for X-linked disorders in the same period. Comparative analysis of ovarian stimulation parameters and results was performed with bivariate and multivariate analysis. Then, among DM1 patients, a correlation between genotype (number of CTG repeats) and ovarian reserve, assessed by antral follicle count, was investigated. Comparative study showed no difference concerning the number of oocytes, embryos and pregnancy rate between the two groups. Multivariate analysis demonstrated that DM1 patients needed a significantly higher dose of gonadotrophins (+544IU, P<0.001) than X-linked disorders patients and suggests a decreased ovarian sensitivity. However, with higher dose of gonadotrophins, PGD for DM1 offers good reproductive outcomes with a clinical pregnancy rate of 35.7%. Genotype was not correlated to ovarian reserve and appeared not to be helpful for the choice of the dose of gonadotrophins. Copyright (c) 2010 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20231114     DOI: 10.1016/j.rbmo.2010.02.003

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  4 in total

1.  The Impact of Pregnancy on Myotonic Dystrophy: A Registry-Based Study.

Authors:  Nicholas E Johnson; Man Hung; Eriko Nasser; Katharine A Hagerman; Wei Chen; Emma Ciafaloni; Chad R Heatwole
Journal:  J Neuromuscul Dis       Date:  2015-10-07

Review 2.  Molecular genetics and genetic testing in myotonic dystrophy type 1.

Authors:  Dušanka Savić Pavićević; Jelena Miladinović; Miloš Brkušanin; Saša Šviković; Svetlana Djurica; Goran Brajušković; Stanka Romac
Journal:  Biomed Res Int       Date:  2013-03-18       Impact factor: 3.411

3.  Preimplantation Genetic Diagnosis for Myotonic Dystrophy Type 1 and Analysis of the Effect of the Disease on the Reproductive Outcome of the Affected Female Patients.

Authors:  Raquel María Fernández; María Dolores Lozano-Arana; Beatriz Sánchez; Ana Peciña; Juan Carlos García-Lozano; Salud Borrego; Guillermo Antiñolo
Journal:  Biomed Res Int       Date:  2017-11-14       Impact factor: 3.411

4.  Anti-Müllerian hormone as an ovarian reserve marker in women with the most frequent muscular dystrophies.

Authors:  Olesja Parmova; Eva Vlckova; Monika Hulova; Livie Mensova; Igor Crha; Petra Stradalova; Eva Kralickova; Lenka Jurikova; Martina Podborska; Radim Mazanec; Ladislav Dusek; Jiri Jarkovsky; Josef Bednarik; Stanislav Vohanka; Iva Srotova
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.